CN101256188A - 检测林可霉素药物的酶联免疫试剂盒及其应用 - Google Patents
检测林可霉素药物的酶联免疫试剂盒及其应用 Download PDFInfo
- Publication number
- CN101256188A CN101256188A CNA2008101041291A CN200810104129A CN101256188A CN 101256188 A CN101256188 A CN 101256188A CN A2008101041291 A CNA2008101041291 A CN A2008101041291A CN 200810104129 A CN200810104129 A CN 200810104129A CN 101256188 A CN101256188 A CN 101256188A
- Authority
- CN
- China
- Prior art keywords
- lincomycin
- enzyme
- liquid
- kit
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 title claims abstract description 155
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 title claims abstract description 153
- 229960005287 lincomycin Drugs 0.000 title claims abstract description 153
- 239000003814 drug Substances 0.000 title claims description 20
- 238000008157 ELISA kit Methods 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 claims abstract description 64
- 108090000790 Enzymes Proteins 0.000 claims abstract description 64
- 239000007788 liquid Substances 0.000 claims abstract description 64
- 238000000034 method Methods 0.000 claims abstract description 43
- 239000000427 antigen Substances 0.000 claims abstract description 40
- 102000036639 antigens Human genes 0.000 claims abstract description 40
- 108091007433 antigens Proteins 0.000 claims abstract description 40
- 238000002372 labelling Methods 0.000 claims abstract description 35
- 238000002965 ELISA Methods 0.000 claims abstract description 30
- 239000012086 standard solution Substances 0.000 claims abstract description 28
- 239000000243 solution Substances 0.000 claims abstract description 20
- 239000012530 fluid Substances 0.000 claims abstract description 11
- 239000000758 substrate Substances 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims description 19
- 238000012360 testing method Methods 0.000 claims description 19
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 15
- 239000011248 coating agent Substances 0.000 claims description 15
- 238000000576 coating method Methods 0.000 claims description 15
- 239000000872 buffer Substances 0.000 claims description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 13
- 102000014914 Carrier Proteins Human genes 0.000 claims description 10
- 108010078791 Carrier Proteins Proteins 0.000 claims description 10
- 210000004408 hybridoma Anatomy 0.000 claims description 10
- 230000001900 immune effect Effects 0.000 claims description 10
- 239000003550 marker Substances 0.000 claims description 10
- 239000008363 phosphate buffer Substances 0.000 claims description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 9
- 229940098773 bovine serum albumin Drugs 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 229940014800 succinic anhydride Drugs 0.000 claims description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 6
- 108010058846 Ovalbumin Proteins 0.000 claims description 5
- 229940092253 ovalbumin Drugs 0.000 claims description 5
- 238000002203 pretreatment Methods 0.000 claims description 5
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 3
- 229940033663 thimerosal Drugs 0.000 claims description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 2
- 102000008946 Fibrinogen Human genes 0.000 claims description 2
- 108010049003 Fibrinogen Proteins 0.000 claims description 2
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 2
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 2
- 239000008351 acetate buffer Substances 0.000 claims description 2
- 229940012952 fibrinogen Drugs 0.000 claims description 2
- 108060003552 hemocyanin Proteins 0.000 claims description 2
- NFJCQBGAUBIGKV-UHFFFAOYSA-N nitro dihydrogen phosphate Chemical compound OP(O)(=O)O[N+]([O-])=O NFJCQBGAUBIGKV-UHFFFAOYSA-N 0.000 claims description 2
- 230000028327 secretion Effects 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims 2
- 235000012907 honey Nutrition 0.000 abstract description 13
- 241001465754 Metazoa Species 0.000 abstract description 12
- 238000001514 detection method Methods 0.000 abstract description 11
- 238000005406 washing Methods 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 7
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 238000012216 screening Methods 0.000 abstract description 5
- 238000012544 monitoring process Methods 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000011161 development Methods 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 238000007781 pre-processing Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 40
- 238000002835 absorbance Methods 0.000 description 18
- 241000699666 Mus <mouse, genus> Species 0.000 description 17
- 241001494479 Pecora Species 0.000 description 17
- 239000012488 sample solution Substances 0.000 description 12
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 12
- 238000011534 incubation Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 230000008878 coupling Effects 0.000 description 9
- 238000010168 coupling process Methods 0.000 description 9
- 238000005859 coupling reaction Methods 0.000 description 9
- 230000036039 immunity Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 150000008064 anhydrides Chemical class 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000031700 light absorption Effects 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 150000001718 carbodiimides Chemical class 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 230000002163 immunogen Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000011587 new zealand white rabbit Methods 0.000 description 3
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical class CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 1
- 244000118681 Iresine herbstii Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- -1 amino amino Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940041028 lincosamides Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1292—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Actinomyces; from Streptomyces (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9446—Antibacterials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101041291A CN101256188B (zh) | 2008-04-16 | 2008-04-16 | 检测林可霉素药物的酶联免疫试剂盒及其应用 |
US12/988,111 US8507214B2 (en) | 2008-04-16 | 2008-09-27 | Elisa kit for detecting lincomycin |
PCT/CN2008/001668 WO2009127094A1 (zh) | 2008-04-16 | 2008-09-27 | 检测林可霉素的酶联免疫试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101041291A CN101256188B (zh) | 2008-04-16 | 2008-04-16 | 检测林可霉素药物的酶联免疫试剂盒及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101256188A true CN101256188A (zh) | 2008-09-03 |
CN101256188B CN101256188B (zh) | 2012-07-11 |
Family
ID=39891165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101041291A Expired - Fee Related CN101256188B (zh) | 2008-04-16 | 2008-04-16 | 检测林可霉素药物的酶联免疫试剂盒及其应用 |
Country Status (3)
Country | Link |
---|---|
US (1) | US8507214B2 (zh) |
CN (1) | CN101256188B (zh) |
WO (1) | WO2009127094A1 (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009127094A1 (zh) * | 2008-04-16 | 2009-10-22 | 北京望尔康泰生物技术有限公司 | 检测林可霉素的酶联免疫试剂盒 |
CN101782579A (zh) * | 2009-11-11 | 2010-07-21 | 北京望尔康泰生物技术有限公司 | 检测泰妙菌素药物的酶联免疫试剂盒及其应用 |
CN101839918A (zh) * | 2009-11-11 | 2010-09-22 | 北京望尔康泰生物技术有限公司 | 一种检测螺旋霉素的方法及其专用酶联免疫试剂盒 |
CN102721809A (zh) * | 2011-03-29 | 2012-10-10 | 库尔医疗技术(北京)有限公司 | 林可霉素检测试剂盒及其制备方法 |
CN102818895A (zh) * | 2012-08-09 | 2012-12-12 | 河南省农业科学院 | 林可霉素残留快速检测试纸条及其制备方法 |
CN103364553A (zh) * | 2012-04-01 | 2013-10-23 | 北京勤邦生物技术有限公司 | 检测硝基咪唑类药物的酶联免疫试剂盒及其应用 |
CN103675287A (zh) * | 2013-12-12 | 2014-03-26 | 洛阳莱普生信息科技有限公司 | 一种伊维菌素化学发光酶联免疫快速检测试剂盒 |
CN104897896A (zh) * | 2015-04-14 | 2015-09-09 | 北京勤邦生物技术有限公司 | 一种林可霉素的磁免疫化学发光检测试剂盒及其应用 |
WO2019129082A1 (zh) * | 2017-12-27 | 2019-07-04 | 江南大学 | 一株林可胺类通用性单克隆抗体杂交瘤细胞株及其应用 |
CN112379098A (zh) * | 2020-11-05 | 2021-02-19 | 集美大学 | 一种水产品中组胺含量的模拟酶标记抗体elisa检测方法 |
CN112526119A (zh) * | 2020-11-13 | 2021-03-19 | 北京元恩生物技术有限公司 | 一种阿奇霉素酶联免疫检测试剂盒及其应用 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109959784A (zh) * | 2017-12-22 | 2019-07-02 | 北京维德维康生物技术有限公司 | 一种三氯卡班半抗原和抗原及其制备方法和用途 |
CN109061172B (zh) * | 2018-09-21 | 2021-07-06 | 中国烟草总公司郑州烟草研究院 | 一种检测仲丁灵的酶联免疫试剂盒及其应用 |
CN110596379B (zh) * | 2019-08-05 | 2023-09-29 | 天津一安生物技术有限公司 | 一种基于elisa的小分子检测试剂盒及检测方法 |
CN111665241B (zh) * | 2020-06-12 | 2023-03-28 | 苏州良辰生物仪器试剂有限公司 | 一种酪氨酸检测试纸条及其制备方法和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0593111B1 (en) * | 1992-10-14 | 1998-06-17 | Agfa-Gevaert N.V. | Antistatic coating composition |
US5998222A (en) * | 1993-11-29 | 1999-12-07 | Utah State University | Reconditioning antibiotic-adulterated milk products |
US20060188523A1 (en) * | 2005-01-10 | 2006-08-24 | Zhiheng Pei | Methods for diagnosing and treating chronic tonsillitis |
CN100397083C (zh) * | 2005-11-03 | 2008-06-25 | 北京望尔生物技术有限公司 | 检测呋喃唑酮代谢物的酶联免疫试剂盒及方法 |
CN100501405C (zh) * | 2005-11-03 | 2009-06-17 | 北京望尔生物技术有限公司 | 检测青霉素g的酶联免疫试剂盒及其方法 |
CN100501409C (zh) | 2005-11-03 | 2009-06-17 | 北京望尔生物技术有限公司 | 一种检测动物源性食品中氯霉素类药物的酶联免疫试剂盒 |
CN100501404C (zh) * | 2005-11-03 | 2009-06-17 | 北京望尔生物技术有限公司 | 检测β-兴奋剂类药物的酶联免疫试剂盒及其方法 |
CN100489530C (zh) | 2006-02-16 | 2009-05-20 | 中国农业大学 | 一种检测磺胺喹噁啉的方法及其专用酶联免疫试剂盒 |
CN101256188B (zh) * | 2008-04-16 | 2012-07-11 | 北京望尔生物技术有限公司 | 检测林可霉素药物的酶联免疫试剂盒及其应用 |
-
2008
- 2008-04-16 CN CN2008101041291A patent/CN101256188B/zh not_active Expired - Fee Related
- 2008-09-27 WO PCT/CN2008/001668 patent/WO2009127094A1/zh active Application Filing
- 2008-09-27 US US12/988,111 patent/US8507214B2/en active Active
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8507214B2 (en) | 2008-04-16 | 2013-08-13 | Beijing Kwinbon Biotechnology Co., Ltd. | Elisa kit for detecting lincomycin |
WO2009127094A1 (zh) * | 2008-04-16 | 2009-10-22 | 北京望尔康泰生物技术有限公司 | 检测林可霉素的酶联免疫试剂盒 |
CN101782579A (zh) * | 2009-11-11 | 2010-07-21 | 北京望尔康泰生物技术有限公司 | 检测泰妙菌素药物的酶联免疫试剂盒及其应用 |
CN101839918A (zh) * | 2009-11-11 | 2010-09-22 | 北京望尔康泰生物技术有限公司 | 一种检测螺旋霉素的方法及其专用酶联免疫试剂盒 |
CN101782579B (zh) * | 2009-11-11 | 2013-07-17 | 北京望尔生物技术有限公司 | 检测泰妙菌素药物的酶联免疫试剂盒及其应用 |
CN102721809A (zh) * | 2011-03-29 | 2012-10-10 | 库尔医疗技术(北京)有限公司 | 林可霉素检测试剂盒及其制备方法 |
CN103364553B (zh) * | 2012-04-01 | 2016-09-21 | 北京勤邦生物技术有限公司 | 检测硝基咪唑类药物的酶联免疫试剂盒及其应用 |
CN103364553A (zh) * | 2012-04-01 | 2013-10-23 | 北京勤邦生物技术有限公司 | 检测硝基咪唑类药物的酶联免疫试剂盒及其应用 |
CN102818895A (zh) * | 2012-08-09 | 2012-12-12 | 河南省农业科学院 | 林可霉素残留快速检测试纸条及其制备方法 |
CN103675287A (zh) * | 2013-12-12 | 2014-03-26 | 洛阳莱普生信息科技有限公司 | 一种伊维菌素化学发光酶联免疫快速检测试剂盒 |
CN103675287B (zh) * | 2013-12-12 | 2015-11-25 | 洛阳莱普生信息科技有限公司 | 一种伊维菌素化学发光酶联免疫快速检测试剂盒 |
CN104897896A (zh) * | 2015-04-14 | 2015-09-09 | 北京勤邦生物技术有限公司 | 一种林可霉素的磁免疫化学发光检测试剂盒及其应用 |
WO2019129082A1 (zh) * | 2017-12-27 | 2019-07-04 | 江南大学 | 一株林可胺类通用性单克隆抗体杂交瘤细胞株及其应用 |
US10808041B2 (en) | 2017-12-27 | 2020-10-20 | Jiangnan University | Lincosamides universal monoclonal antibody hybridoma cell strain and application thereof |
CN112379098A (zh) * | 2020-11-05 | 2021-02-19 | 集美大学 | 一种水产品中组胺含量的模拟酶标记抗体elisa检测方法 |
CN112526119A (zh) * | 2020-11-13 | 2021-03-19 | 北京元恩生物技术有限公司 | 一种阿奇霉素酶联免疫检测试剂盒及其应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2009127094A1 (zh) | 2009-10-22 |
CN101256188B (zh) | 2012-07-11 |
US8507214B2 (en) | 2013-08-13 |
US20110111440A1 (en) | 2011-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101256188B (zh) | 检测林可霉素药物的酶联免疫试剂盒及其应用 | |
CN100403030C (zh) | 检测苏丹红药物的酶联免疫试剂盒及方法 | |
CN101013129B (zh) | 检测呋喃西林代谢物的酶联免疫试剂盒及其应用 | |
CN101571539B (zh) | 检测头孢类药物的酶联免疫试剂盒及其应用 | |
CN101571541B (zh) | 检测磺胺类药物的酶联免疫试剂盒及其方法 | |
CN100501410C (zh) | 一种检测动物源性食品中莱克多巴胺的酶联免疫试剂盒 | |
CN100397083C (zh) | 检测呋喃唑酮代谢物的酶联免疫试剂盒及方法 | |
CN101776685B (zh) | 检测三甲氧苄胺嘧啶药物的酶联免疫试剂盒及其应用 | |
CN100501409C (zh) | 一种检测动物源性食品中氯霉素类药物的酶联免疫试剂盒 | |
CN101013130A (zh) | 检测呋喃它酮代谢物的酶联免疫试剂盒及其应用 | |
CN101241134B (zh) | 检测莱克多巴胺残留的酶联免疫试剂盒及使用方法 | |
CN101021536B (zh) | 检测新霉素药物的酶联免疫试剂盒及方法 | |
CN101839918B (zh) | 一种检测螺旋霉素的方法及其专用酶联免疫试剂盒 | |
CN1811436B (zh) | 一种检测恩诺沙星的方法及其专用酶联免疫试剂盒 | |
CN101021535B (zh) | 检测庆大霉素药物的酶联免疫试剂盒及方法 | |
CN101358967B (zh) | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 | |
CN101571540B (zh) | 检测猪免疫球蛋白g的酶联免疫试剂盒及其应用 | |
CN101013131B (zh) | 呋喃妥因代谢物酶联免疫分析试剂盒及其应用 | |
CN100489530C (zh) | 一种检测磺胺喹噁啉的方法及其专用酶联免疫试剂盒 | |
CN101299046B (zh) | 一种检测红霉素类化合物的方法及其专用酶联免疫试剂盒 | |
CN101782579B (zh) | 检测泰妙菌素药物的酶联免疫试剂盒及其应用 | |
CN100476439C (zh) | 一种检测动物源性食品中氟喹酮类药物的酶联免疫试剂盒 | |
CN103364553A (zh) | 检测硝基咪唑类药物的酶联免疫试剂盒及其应用 | |
CN103018451A (zh) | 检测氯霉素的酶联免疫试剂盒及其应用 | |
CN103018447B (zh) | 检测沙丁胺醇的酶联免疫试剂盒及其方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING WANGER BIOTECHNOLOGY CO., LTD. Effective date: 20120528 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 102200 CHANGPING, BEIJING TO: 100094 HAIDIAN, BEIJING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120528 Address after: 100094 Beijing city Haidian District Old Summer Palace West Hospital No. 2 room 10 Applicant after: Beijing Wanger Biotechnology Co.,Ltd. Address before: 102200 Beijing science and Technology Park of Changping District Bai Fu Road 10 Beikong science and technology building, room 1109A Applicant before: Beijing Wanger Kangtai Biotechnology Co.,Ltd. Co-applicant before: Beijing Wanger Biotechnology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120711 |
|
CF01 | Termination of patent right due to non-payment of annual fee |